Iovance Biotherapeutics Inc (IOVA) receives a Buy rating from UBS
In a filing, Iovance Biotherapeutics Inc revealed its Director Maynard Ryan D unloaded Company’s shares for reported $0.5 million on
In a filing, Iovance Biotherapeutics Inc revealed its Director Maynard Ryan D unloaded Company’s shares for reported $0.5 million on
Iovance Biotherapeutics Inc’s recently made public that its Director Maynard Ryan D acquired Company’s shares for reported $0.5 million on
In a filing, Iovance Biotherapeutics Inc revealed its Director MCPEAK MERRILL A acquired Company’s shares for reported $2.29 million on
Iovance Biotherapeutics Inc’s recently made public that its Director MCPEAK MERRILL A acquired Company’s shares for reported $2.29 million on
In a filing, Iovance Biotherapeutics Inc revealed its Director MCPEAK MERRILL A acquired Company’s shares for reported $2.29 million on
Iovance Biotherapeutics Inc’s recent filing unveils that its Director MCPEAK MERRILL A acquired Company’s shares for reported $2.29 million on
Iovance Biotherapeutics Inc’s recent filing unveils that its Director MCPEAK MERRILL A acquired Company’s shares for reported $2.29 million on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.